Recent news that Halifax-based Immunovaccine (TSXV:IMV) was pulling its proposed public financing due to market conditions could be a sign that the … [Read more...] about Canadian Biotech is Healthy, Regardless of Financing Climate
A recent dip in the price of Lorus Therapeutics (TSX:LOR) has one insider scooping up more shares. On April 17th, Pinetree Capital CEO and Lorus … [Read more...] about Insider buying at Lorus Therapeutics
The trading halt on shares of Lorus Therapeutics (TSX:LOR) was lifted this morning after the company announced it will partner with Cancer Research … [Read more...] about Lorus Therapeutics partners with Cancer Research U.K.
Investors haven't been crying over the performance of TearLab, shares of the company are up more than 200% in just the first six months of … [Read more...] about Canada’s 10 Hottest Biotech Stocks